1. Adams JU, Paronis CA, Holtzman SG (1990) Assessment of relative intrinsic activity of μ-opioid analgesic in vivo by using β-funaltrexamine. J Pharmacol Exp Ther 255: 1027–1032
2. Arunlakshana O, Schild H (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14: 48–58
3. Burke TF, Woods JH, Lewis JW, Medzihradsky F (1994) Irreversible opioid antagonist effects of clocinnamox on opioid analgesics andmu receptor binding in mice. J Pharmacol Exp Ther 271: 650–661
4. Comer SD, Burke TF, Lewis JW, Woods JH (1992) Clocinnamox: a novel, systemically-active, irreversible opioid antagonist. J Pharmacol Exp Ther 262[3]: 1051–1056
5. Dum J, Blasig J, Meyer G, Herz A (1979)In vivo opiate binding unchanged in tolerant/dependent mice. Eur J Pharmacol 55: 375–383